Integration of histone modification-based risk signature with drug sensitivity analysis reveals novel therapeutic strategies for lower-grade glioma.

Front Pharmacol · 2024 · PMC11770009 · PMID 39872055

Europe PMC DOI

hedged sentences

0.0560

closest p · 1.1× alpha

0.1160

boldest claim

The sentences

showed a trendp = 0.056so close (0.05 < p ≤ 0.1)

Liver Hepatocellular Carcinoma (LIHC) showed a trend toward increased risk (HR = 1.35, p = 0.056). 3.

also in 53,322 other papers

did not reach statistical significancep = 0.116not close (p > 0.1)

Thymoma (THYM), despite having the highest hazard ratio (HR = 3.55), did not reach statistical significance ( p = 0.116), possibly due to limited sample size (n = 121).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.